Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP329104.RAjnP3vTOF2Dr_f7XuSmYMO7dIO2rV0Jpfv5HKYhAyYtA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP329104.RAjnP3vTOF2Dr_f7XuSmYMO7dIO2rV0Jpfv5HKYhAyYtA130_assertion type Assertion NP329104.RAjnP3vTOF2Dr_f7XuSmYMO7dIO2rV0Jpfv5HKYhAyYtA130_head.
- NP329104.RAjnP3vTOF2Dr_f7XuSmYMO7dIO2rV0Jpfv5HKYhAyYtA130_assertion description "[Patients suffering from the metabolic disease hereditary tyrosinemia type I (HT1), caused by fumarylacetoacetate hydrolase deficiency, have a high risk of developing liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329104.RAjnP3vTOF2Dr_f7XuSmYMO7dIO2rV0Jpfv5HKYhAyYtA130_provenance.
- NP329104.RAjnP3vTOF2Dr_f7XuSmYMO7dIO2rV0Jpfv5HKYhAyYtA130_assertion evidence source_evidence_literature NP329104.RAjnP3vTOF2Dr_f7XuSmYMO7dIO2rV0Jpfv5HKYhAyYtA130_provenance.
- NP329104.RAjnP3vTOF2Dr_f7XuSmYMO7dIO2rV0Jpfv5HKYhAyYtA130_assertion SIO_000772 11532983 NP329104.RAjnP3vTOF2Dr_f7XuSmYMO7dIO2rV0Jpfv5HKYhAyYtA130_provenance.
- NP329104.RAjnP3vTOF2Dr_f7XuSmYMO7dIO2rV0Jpfv5HKYhAyYtA130_assertion wasDerivedFrom befree-2016 NP329104.RAjnP3vTOF2Dr_f7XuSmYMO7dIO2rV0Jpfv5HKYhAyYtA130_provenance.
- NP329104.RAjnP3vTOF2Dr_f7XuSmYMO7dIO2rV0Jpfv5HKYhAyYtA130_assertion wasGeneratedBy ECO_0000203 NP329104.RAjnP3vTOF2Dr_f7XuSmYMO7dIO2rV0Jpfv5HKYhAyYtA130_provenance.